The ‘WOLVERINE’ Stack
Comprehensive Recovery Stack (BPC-157 + TB-500/TB4)
WHAT IT IS:
A combination protocol pairing BPC-157 and TB-500/TB4 in a single regimen — bringing together localized tissue repair and systemic, whole-body recovery support in one powerhouse stack.
WHY YOU NEED IT:
Two Complementary Repair Pathways in One Protocol
Important for patients recovering from significant or multiple soft-tissue injuries
Supports patients who want both site-specific and whole-body recovery support
Good for active patients and athletes managing challenging training and competition schedules
Great for patients who prefer one coordinated stack rather than juggling separate protocols
Supports patients seeking to address both tissue repair and inflammation together
Important for patients pursuing a structured, physician-guided recovery plan
HOW IT HELPS:
The “Wolverine” nickname reflects the goal of this stack: to support the body's capacity to bounce back as quickly as possible. It combines two of the most researched recovery peptides, and provides a stack in which their strengths overlap.
BPC-157 — Localized Repair
BPC-157 is a synthetic peptide based on a protective compound found in the stomach. In research models, it is associated with localized support for tendon, ligament, muscle, and gut tissue, partly through promoting new blood-vessel formation and modulating healing pathways at the site of injury.
TB-500/TB4 — Systemic Support
TB-500, derived from the active region of Thymosin Beta-4, circulates throughout the body and is thought to enhance cell migration, blood-vessel formation, and inflammation control on a systemic level. Both TB-500 and TB4 make them a natural partner to BPC-157's more local action.
Why Combine Them
Because the two peptides act through different but complementary mechanisms and have different half-lives, they are frequently stacked together. A blended protocol simplifies the regimen while aiming to cover both local and systemic recovery.
The evidence base for both compounds is largely preclinical, with strong and repeated animal findings but limited direct human trials. Reported side effects are generally mild.
Who Should Not Use Wolverine Blend
This blend is not appropriate for patients with active malignancy or significant cancer risk (due to the angiogenic activity of both components), women who are pregnant or breastfeeding, or patients with known hypersensitivity to either peptide. Due to the recognized physiological advantages, it is banned by most athletic anti-doping organizations. Use only under physician supervision.
DOSAGE:
Titration: Exact doses, ratios, and cycle length should be individualized and overseen by a physician; reconstitute with bacteriostatic water using sterile technique and rotate injection sites.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.